Pre-market trading is offering an early glimpse into biotech stocks likely to attract investor attention this Wednesday.
Significant price moves ahead of the opening bell are being driven by clinical trial updates, public and private offerings and corporate developments.
Assessing sentiment and momentum in the premarket sets the tone for a trader's day.
In the Green - Premarket Gainers
On Wednesday, the following stocks were trading significantly higher in the premarket session.
1. Picard Medical, Inc. (PMI) - up 34% at $0.362. Connect Biopharma Holdings Limited.(CNTB) - up 14% at $2.443. Rezolute, Inc. (RZLT) - up 8% at $4.314. Kairos Pharma, Ltd. (KAPA) - up 7% at $0.495. Nuwellis, Inc.. (NUWE) - up 8% at $0.646. LifeVantage Corporation. (LFVN) - up 10% at $9.467. Mustang Bio, Inc. (MBIO) - up 7% at $0.818. Profusa, Inc. (PFSA) - up 8% at $0.359. INVO Fertility, Inc. (IVF) - up 9% at $1.6610. Actuate Therapeutics, Inc. (ACTU) - up 8% at $2.03
In the Red - Premarket Losers
The following stocks were trading lower in the premarket session on Wednesday.
1. TransCode Therapeutics, Inc. (RNAZ) - down 22% at $4.132. Soligenix, Inc. (SNGX) - down 20% at $0.603. NRx Pharmaceuticals, Inc. (NRXP) - down 21% at $3.654. AIM ImmunoTech Inc. (AIM) - down 16% at $0.705. Basel Medical Group Ltd. (BMGL) - down 25% at $0.416. Bluejay Diagnostics, Inc.. (BJDX) - down 14% at $3.727. Dogwood Therapeutics, Inc. (DWTX) - down 7% at $1.758. Jin Medical International Ltd. (ZJYL) - down 10% at $2.93.9. Aethlon Medical, Inc. (AEMD) - down 5% at $2.0910. IceCure Medical Ltd. (ICCM) - down 6% at $0.13
For More Such Biotech Stock News, visit rttnews.com.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.